A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

A new review found as many as 45% of Type 2 diabetics are suffering multiple deficiencies in vitamins, minerals and ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Around 20 million Americans reportedly trust this medication—here are the recall details, and the unusual error that caused ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

The study methodology involved comparing SGLT-2 inhibitor users with those taking DPP-4 inhibitors, another common diabetes medication class. Results showed participants using SGLT-2 inhibitors ...

If your constipation lasts for more than three days, speak with your doctor about options to help. You might need to add a ...

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

Antipsychotics, some medications for high blood pressure, diabetes medications ... and reasoning difficulties and language problems are common early symptoms of the condition, which then worsen ...

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...